Clinical Trial Update: Observational Study on the Use of NovoSeven® for Haemostatic Treatment of Bleeding Episodes in Patients With Acquired Haemophilia

View source ↗

Summary

This completed observational study evaluates the use of NovoSeven (recombinant factor VIIa) for haemostatic treatment of bleeding episodes in patients with acqu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Bleeding Disorders
• Acquired Haemophilia

Drugs mentioned

• NovoSeven (recombinant coagulation factor VIIa)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Acquired Bleeding Disorder, Acquired Haemophilia | Status: COMPLETED